Why the study?
Does the deletion of the NH2-terminal and/or rod domains of dystrophin affect the expression of dystrophin-associated proteins in the sarcolemma of patients with Becker/Duchenne muscular dystrophy?
Population
8 male patients with Becker/Duchenne muscular dystrophy who had huge in-frame deletions in the NH2-terminal…
Comparison
Immunohistochemical analysis of skeletal muscle… vs Normal human muscle, typical DMD muscle, and…
Design
Case_series
Authors
Loading...
Case reports suggest domain deletions spare severe DAP loss; leaves open whether actin-binding defects drive degeneration in dystrophinopathies.
Does the deletion of the NH2-terminal and/or rod domains of dystrophin affect the expression of dystrophin-associated proteins in the sarcolemma of patients with Becker/Duchenne muscular dystrophy?
The NH2-terminal and rod domains of dystrophin may not be essential for interaction with the sarcolemmal glycoprotein complex, suggesting that defects in actin binding activity may disrupt anchorage and render muscle fibers susceptible to degeneration.
Matsumura et al. (1994) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: